Pharmabiz5h
Cassava Sciences’ ReThink-ALZ phase 3 study of simufilam in mild-to-moderate AD fails to meet co-primary endpoints
Cassava Sciences, Inc., a clinical-stage biotechnology company focused on developing a novel, investigational treatment for Alzheimer’s disease (AD) dementia, announced that the topline results from ...
Pharmabiz14h
Bry-Air conducts 14th Biannual Eye Camp at Moga, Punjab, to celebrate 60 years of the company
Bry-Air conducts 14th Biannual Eye Camp at Moga, Punjab, to celebrate 60 years of the company: Our Bureau, Mumbai Wednesday, ...
Pharmabiz13h
Johnson & Johnson unveils ‘India Detects to Defeat’ initiative to urge for early lung cancer detection and testing
Johnson & Johnson unveils ‘India Detects to Defeat’ initiative to urge for early lung cancer detection and testing: Our Bureau, Mumbai Wednesday, November 27, 2024, 14:45 Hrs ...
Pharmabiz11h
BioNxt reports expansion of its next-generation product pipeline with innovative solutions for autoimmune diseases and longevity
BioNxt reports expansion of its next-generation product pipeline with innovative solutions for autoimmune diseases and longevity: Vancouver, BC Wednesday, November 27, 2024, 17:00 ...
Pharmabiz15h
Rajesh Narvekar takes charge as Maharashtra FDA Commissioner
The Maharashtra government has appointed Rajesh Narvekar as the new Commissioner of the Food and Drug Administration (FDA), Maharashtra. Narvekar officially assumed charge last week, filling a post ...
Pharmabiz14h
Centrum addresses growing joint health concerns with launch of Centrum Joint & Mobility Capsule in India
Centrum addresses growing joint health concerns with launch of Centrum Joint & Mobility Capsule in India: Our Bureau, Mumbai Wednesday, November 27, 2024, 14:30 Hrs [IST] Centrum, ...
Pharmabiz12h
Abbott announces first step toward its software-guided balloon-expandable TAVI System to treat aortic stenosis
Abbott announces first step toward its software-guided balloon-expandable TAVI System to treat aortic stenosis: Abbott Park, Illinois Wednesday, November 27, 2024, 16:00 Hrs [IST] ...
Pharmabiz16h
Empyrean Therapeutics acquires TLR-2 antagonist molecule from Eos Therapies to advance and commercialize breakthrough cancer treatment
Empyrean Therapeutics acquires TLR-2 antagonist molecule from Eos Therapies to advance and commercialize breakthrough cancer treatment: Boca Raton, Florida Wednesday, November 27, ...
Pharmabiz17h
ReviR Therapeutics & Kennedy's Disease Association partner to advance treatment for rare neuromuscular disorder
ReviR Therapeutics & Kennedy's Disease Association partner to advance treatment for rare neuromuscular disorder: Brisbane, California Wednesday, November 27, 2024, 11:00 Hrs [IST] ...
Pharmabiz18h
Boehringer Ingelheim introduces US FDA approved VETMEDIN Solution for congestive heart failure in dogs
Boehringer Ingelheim introduces US FDA approved VETMEDIN Solution for congestive heart failure in dogs: Ingelheim Wednesday, November 27, 2024, 10:00 Hrs [IST] Boehringer Ingelhei ...
Pharmabiz16h
Glenmark Pharmaceuticals introduces travoprost ophthalmic solution USP, 0.004% in US
Glenmark Pharmaceuticals introduces travoprost ophthalmic solution USP, 0.004% in US: Our Bureau, Mumbai Wednesday, November 27, 2024, 12:15 Hrs [IST] Glenmark Pharmaceuticals Inc ...
Pharmabiz19h
Roche inks agreement to acquire clinical-stage biopharma company, Poseida Therapeutics
Roche inks agreement to acquire clinical-stage biopharma company, Poseida Therapeutics: Basel Wednesday, November 27, 2024, 09:00 Hrs [IST] Roche announced that it has entered int ...